ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$13.82 +0.73%

+$0.13 today

Market cap
$1.53B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.70M

Average 1.06M

Returns on capital

ADARx Pharmaceuticals, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

No return metrics data available.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Li Zhen

Co-Founder, President, CEO & DirectorUSD 875.41K65——

Zhen Li

Co-Founder, President, CEO & DirectorUSD 875.41K64——

Robert A. MacLeod

Chief Scientific OfficerUSD 640.51K59——

Ryan Fisk

CFO & Chief Business Officer—44——

Christopher Claeboe

Senior Vice President of Operations————

Rui Zhu

Chief Technology Officer—43——

Jiang Bian

VP & Head of Legal————

Robert Ackles

Chief People Officer—61——

Compensation is shown in the reported currency; data updated Nov 14, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

No growth data available

Competitors

Who does ADARx Pharmaceuticals, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about ADRX's management, answered from reported figures.

Who manages ADRX?

ADARx Pharmaceuticals, Inc. (ADRX) lists 8 active executives. The top listed executive is Li Zhen, Co-Founder, President, CEO & Director.

Are ADRX insiders buying or selling?

Recent insider activity shows net selling of $6.84M.